Español
Русский
No products in the cart.
SUFFERING FROM ANY KIND OF DISEASES?
Premilife gives energy to the human body that increases the chances of winning diseases (which diseases? more than 700!) - the means - homeopathic remedies
Aciamit
$1,380.00 – $4,416.00
Based on the individual homeopathic constituents of Aciamit therapeutical possibilities result for the treatment of Neurogenic Bladder.
For 6 months only: 230$ per month.
For 12 months only: 213$ per month.
For 24 months only: 184$ per month.
All of us at Premilife are motivated by the constant desire to improve quality of life. As we work tirelessly to deliver improved health and wellbeing, our first responsibility is always to our patients, their loved ones, and the healthcare professionals who use our treatments. We work constantly in order to innovate and develop the most advanced homeopathic remedies based on the latest scientific and clinical research, conducted by leading doctors and pharmacists.
Be the first to review “Aciamit”
Related products
Racilex - Diabetes Insipidus
Kidneys and Urinary System
$1,430.00 – $4,576.00
Deroxitol - Polycystic Kidney Disease
Kidneys and Urinary System
$1,425.00 – $4,560.00
Sinetax - Nephritis
Kidneys and Urinary System
$1,350.00 – $4,320.00
Neurapercyl - Chemotherapy Side Effect - Chemotherapy Induced Peripheral Neuropathy
Brain and Nervous System
$1,600.00 – $5,120.00
Cycloxan - Urethral Cancer
Kidneys and Urinary System
$1,500.00 – $4,800.00
Carcinexon - Cancer
Brain and Nervous System
$1,580.00 – $5,056.00
Radexin - Bladder Cancer
Kidneys and Urinary System
$1,500.00 – $4,800.00
Immuxatel - Chemotherapy Side Effect - Bone Marrow Suppression
Brain and Nervous System
$1,585.00 – $5,072.00
Denzeral - Proteinuria
Kidneys and Urinary System
$1,360.00 – $4,352.00
Mytalep - Interstitial Cystitis
Kidneys and Urinary System
$1,350.00 – $4,320.00
Hanbitar - Dysuria
Kidneys and Urinary System
$1,350.00 – $4,320.00
Baryoten - Overactive Bladder
Kidneys and Urinary System
$1,355.00 – $4,336.00
Reviews
There are no reviews yet.